Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jan 23;505(7484):492-3.
doi: 10.1038/505492a.

HIV: Not-so-innocent bystanders

Affiliations
Comment

HIV: Not-so-innocent bystanders

Andrea L Cox et al. Nature. .

Abstract

A new mechanism to explain massive depletion of CD4+ T cells in HIV-1 infection despite the low frequency of productively infected cells involves innate immune sensing of HIV 1 by abortively infected “bystander” CD4+ T cells. The result is death of the bystander cells through an inflammatory process known as pyroptosis. These findings may provide long sought explanations for both CD4+ T cell depletion and HIV-associated inflammation. See Article on page X.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Following HIV-1 infection, most lymphoid CD4+ T cell death is mediated by caspase-1 activation and pyroptosis in abortively infected quiescent CD4+ T cells
A. Productively infected CD4+ T cells represent the minority of dying CD4+ T cells and undergo death via caspase-3 mediated apoptosis. B. The majority of CD4+ T cell death results from caspase-1 mediated pyroptosis in quiescent CD4+ T cells. Abortive infection of quiescent CD4+ T cells, in which incomplete HIV-1 transcripts accumulate and are sensed by the host DNA sensor IFI16, results in caspase-1 cleavage and activation with 1) selective depletion of CD4+ T cells via pyroptosis and 2) release of the highly inflammatory cytokine IL-1β. HIV-1-induced CD4+ T cell death via pyroptosis was blocked by a caspase-1 inhibitor and antiretroviral agents that act on early stages of the HIV-1 life cycle.

Comment on

References

    1. Gottlieb MS, et al. N.Engl.J.Med. 1981;305:1425–1431. - PubMed
    1. Ho DD, et al. Nature. 1995;373:123–126. - PubMed
    1. Wei X, et al. Nature. 1995;373:117–122. - PubMed
    1. Veazey RS, et al. Science. 1998;280:427–431. - PubMed
    1. Brenchley JM, et al. Nat.Med. 2006;12:1365–1371. - PubMed